Guggenheim Maintains Buy on Neogen, Raises Price Target to $14

Benzinga Newsdesk www.benzinga.com Positive 84.3%

Neg 0% Neu 0% Pos 84.3%

Guggenheim analyst Subbu Nambi maintains Neogen (NASDAQ:NEOG) with a Buy and raises the price target from $12 to $14.

Comments

No comments yet. Be the first!